MktsMarkets

ACADIA Pharmaceuticals Inc.
NASDAQ: ACADKey statistics
ACAD News
Stories mentioning ACAD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 268,062 | 283,989 | 278,633 | 264,566 | 244,317 | 259,602 | 250,401 | 241,963 |
| Cost of Goods Sold | 24,791 | 26,225 | 21,647 | 20,734 | 20,392 | 21,803 | 18,857 | 18,230 |
| Gross Profit | 243,271 | 257,764 | 256,986 | 243,832 | 223,925 | 237,799 | 231,544 | 223,733 |
| Operating Expenses | ||||||||
| Research & Development | 76,868 | 84,757 | 87,829 | 77,951 | 78,265 | 100,731 | 66,606 | 76,233 |
| Sales General & Admin | 171,019 | 155,616 | 133,401 | 133,507 | 126,370 | 130,080 | 133,294 | 117,063 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (4,616) | 17,391 | 35,756 | 32,374 | 19,290 | 153,503 | 31,644 | 30,437 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 542.00 | 596.00 | 593.00 | 594.00 | 588.00 | 575.00 | 576.00 | 386.00 |
| Pretax Income | 3,981 | 26,319 | 44,595 | 40,211 | 27,779 | 161,085 | 38,806 | 37,182 |
| Tax Provision | 344.00 | (247,249) | (27,184) | 13,545 | 8,792 | 17,343 | 6,041 | 3,793 |
| Net Income (Loss) | 3,637 | 273,568 | 71,779 | 26,666 | 18,987 | 143,742 | 32,765 | 33,389 |
| Earnings Per Share (Basic) | 0.02 | 1.62 | 0.43 | 0.16 | 0.11 | 0.87 | 0.20 | 0.20 |
| Earnings Per Share (Diluted) | 0.02 | 1.61 | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 |
| Weighted Average Shares Outstanding (Basic) | 170,517 | 168,356 | 168,836 | 167,827 | 166,808 | 165,717 | 165,974 | 165,551 |
| Weighted Average Shares Outstanding (Diluted) | 172,706 | 169,919 | 170,650 | 168,681 | 167,668 | 166,362 | 166,178 | 166,174 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is a stock listed on the Nasdaq Stock Market under the ticker symbol ACAD. It last traded at $18.75 (Nov 13, 2026, 4:00 PM ET), up 3.4% on the day. That gives ACADIA Pharmaceuticals a market capitalisation of $3.1B and a price-to-earnings ratio of 8.7.
Over the past 52 weeks ACAD has traded between $15.86 and $30.96.
Revenue for the quarter ended Mar 31, 2026 was $268.1M; net income $3.6M. Revenue was up 9.7% from $244.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $268.1M | $3.6M | 1.4% |
| Dec 31, 2025 | $284.0M | $273.6M | 96.3% |
| Sep 30, 2025 | $278.6M | $71.8M | 25.8% |
| Jun 30, 2025 | $264.6M | $26.7M | 10.1% |
From ACADIA Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…